Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Mondaca, Sebastian, Margolis, Matthew, Sanchez-Vega, Francisco, Jonsson, Philip, Riches, Jamie C., Ku, Geoffrey Y., Hechtman, Jaclyn F., Tuvy, Yaelle, Berger, Michael F., Shah, Manish A., Kelsen, David P., Ilson, David H., Yu, Kenneth, Goldberg, Zoe, Epstein, Andrew S., Desai, Avni, Chung, Vincent, Chou, Joanne F., Capanu, Marinela, Solit, David B., Schultz, Nikolaus, Janjigian, Yelena Y.
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.03.2019)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.03.2019)
Get full text
Journal Article
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
Janjigian, Yelena Y, Sanchez-Vega, Francisco, Jonsson, Philip, Chatila, Walid K, Hechtman, Jaclyn F, Ku, Geoffrey Y, Riches, Jamie C, Tuvy, Yaelle, Kundra, Ritika, Bouvier, Nancy, Vakiani, Efsevia, Gao, Jianjiong, Heins, Zachary J, Gross, Benjamin E, Kelsen, David P, Zhang, Liying, Strong, Vivian E, Schattner, Mark, Gerdes, Hans, Coit, Daniel G, Bains, Manjit, Stadler, Zsofia K, Rusch, Valerie W, Jones, David R, Molena, Daniela, Shia, Jinru, Robson, Mark E, Capanu, Marinela, Middha, Sumit, Zehir, Ahmet, Hyman, David M, Scaltriti, Maurizio, Ladanyi, Marc, Rosen, Neal, Ilson, David H, Berger, Michael F, Tang, Laura, Taylor, Barry S, Solit, David B, Schultz, Nikolaus
Published in Cancer discovery (01.01.2018)
Published in Cancer discovery (01.01.2018)
Get full text
Journal Article
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer
Greally, Megan, Chou, Joanne F, Chatila, Walid K, Margolis, Matthew, Capanu, Marinela, Hechtman, Jaclyn F, Tuvy, Yaelle, Kundra, Ritika, Daian, Foysal, Ladanyi, Marc, Kelsen, David P, Ilson, David H, Berger, Michael F, Tang, Laura H, Solit, David B, Diaz, Jr, Luis A, Schultz, Nikolaus, Janjigian, Yelena Y, Ku, Geoffrey Y
Published in Clinical cancer research (15.10.2019)
Published in Clinical cancer research (15.10.2019)
Get full text
Journal Article
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2 -Amplified Esophagogastric Cancer
Sanchez-Vega, Francisco, Hechtman, Jaclyn F, Castel, Pau, Ku, Geoffrey Y, Tuvy, Yaelle, Won, Helen, Fong, Christopher J, Bouvier, Nancy, Nanjangud, Gouri J, Soong, Joanne, Vakiani, Efsevia, Schattner, Mark, Kelsen, David P, Lefkowitz, Robert A, Brown, Karen, Lacouture, Mario E, Capanu, Marinela, Mattar, Marissa, Qeriqi, Besnik, Cecchi, Fabiola, Tian, Yuan, Hembrough, Todd, Nagy, Rebecca J, Lanman, Richard B, Larson, Steven M, Pandit-Taskar, Neeta, Schöder, Heiko, Iacobuzio-Donahue, Christine A, Ilson, David H, Weber, Wolfgang A, Berger, Michael F, de Stanchina, Elisa, Taylor, Barry S, Lewis, Jason S, Solit, David B, Carrasquillo, Jorge A, Scaltriti, Maurizio, Schultz, Nikolaus, Janjigian, Yelena Y
Published in Cancer discovery (01.02.2019)
Published in Cancer discovery (01.02.2019)
Get full text
Journal Article
Actionable alterations (AA) in gastrointestinal (GI) cancers: Rate of detection and receipt of matched therapies (MT)
Greally, Megan, Tuvy, Yaelle, Millang, Brittanie M, O'Reilly, Eileen Mary, Yaeger, Rona, Saltz, Leonard B., Ku, Geoffrey Yuyat
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer
Won, Elizabeth, Basunia, Azfar, Chatila, Walid K, Hechtman, Jaclyn F, Chou, Joanne F, Ku, Geoffrey Y, Chalasani, Sree B, Boyar, Michelle S, Goldberg, Zoe, Desai, Avni M, Tuvy, Yaelle, Berger, Michael F, Tang, Laura, Kelsen, David P, Schattner, Mark, Ilson, David H, Capanu, Marinela, Solit, David B, Schultz, Nikolaus, Janjigian, Yelena Y
Published in Clinical cancer research (01.07.2019)
Published in Clinical cancer research (01.07.2019)
Get full text
Journal Article
Tumor mutation burden (TMB) and immune-related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)
Greally, Megan, Chatila, Walid K, Margolis, Matthew, Hechtman, Jaclyn Frances, Tuvy, Yaelle, Kundra, Ritika, Ladanyi, Marc, Kelsen, David Paul, Ilson, David H., Berger, Michael F., Tang, Laura H., Solit, David B., Schultz, Nikolaus, Janjigian, Yelena Yuriy, Ku, Geoffrey Yuyat
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)
Janjigian, Yelena Yuriy, Jonsson, Philip, Kemel, Yelena, Joseph, Vijai, Tuvy, Yaelle, Shameer, Zarina, Ravichandran, Vignesh, Zhang, Liying, Mandelker, Diana, Ku, Geoffrey Yuyat, Hechtman, Jaclyn Frances, Kelsen, David Paul, Ilson, David H., Offit, Kenneth, Berger, Michael F., Schultz, Nikolaus, Robson, Mark E., Solit, David B., Taylor, Barry S., Stadler, Zsofia Kinga
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
Ku, Geoffrey Yuyat, Sanchez-Vega, Francisco, Chatila, Walid, Margolis, Matthew, Fein, Carly, Ilson, David H., Hechtman, Jaclyn Frances, Tuvy, Yaelle, Bouvier, Nancy, Kundra, Ritika, Shia, Jinru, Heins, Zachary J., Middha, Sumit, Zehir, Ahmet, Ladanyi, Marc, Berger, Michael F., Tang, Laura H., Solit, David B., Schultz, Nikolaus, Janjigian, Yelena Yuriy
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer
Ku, Geoffrey Y, Kemel, Yelena, Maron, Steve B, Chou, Joanne F, Ravichandran, Vignesh, Shameer, Zarina, Maio, Anna, Won, Elizabeth S, Kelsen, David P, Ilson, David H, Capanu, Marinela, Strong, Vivian E, Molena, Daniela, Sihag, Smita, Jones, David R, Coit, Daniel G, Tuvy, Yaelle, Cowie, Kendall, Solit, David B, Schultz, Nikolaus, Hechtman, Jaclyn F, Offit, Kenneth, Joseph, Vijai, Mandelker, Diana, Janjigian, Yelena Y, Stadler, Zsofia K
Published in JAMA network open (01.07.2021)
Published in JAMA network open (01.07.2021)
Get full text
Journal Article
Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
Janjigian, Yelena Yuriy, Sanchez-Vega, Francisco, Tuvy, Yaelle, Bouvier, Nancy, Riches, Jamie Cathleen, Margolis, Matthew, Millang, Brittanie M, Scott, Sasinya N., Kundra, Ritika, Castel, Pau, Ku, Geoffrey Yuyat, Hechtman, Jaclyn Frances, Kelsen, David Paul, Ilson, David H., Vakiani, Efsevia, Scaltriti, Maurizio, Solit, David B., Taylor, Barry S., Berger, Michael F., Schultz, Nikolaus
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article